There are several limitations to our study, which are as follows: (1) we must admit that there is a possibility of false positives in hypothesis testing; (2) we did not have enough CAD patients to identify the relationship between IFN-β and CAD; (3) the febrile control cohort in our study mainly suffers from respiratory tract infection. This evidence concerns the gene IFNB1 and coronary artery disorder.